TargetMitogen-activated protein kinase 1 [D319N](Mus musculus (mouse))
University Of Maryland, Baltimore
US Patent
University Of Maryland, Baltimore
US Patent
Affinity DataKd: 1.90E+3nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 1 [D319N](Mus musculus (mouse))
University Of Maryland, Baltimore
US Patent
University Of Maryland, Baltimore
US Patent
Affinity DataKd: 7.00E+3nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 1 [D319N](Mus musculus (mouse))
University Of Maryland, Baltimore
US Patent
University Of Maryland, Baltimore
US Patent
Affinity DataKd: 1.34E+4nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 1 [D319N](Mus musculus (mouse))
University Of Maryland, Baltimore
US Patent
University Of Maryland, Baltimore
US Patent
Affinity DataKd: 1.80E+4nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair